4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-018291
President, R&D sold 10,000 shares at $25.00 ($250,000)
- President, R&D acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergstrom Donald A President, R&D | 2022-03-10 | Option exercise | +10,000 | $4.12 | $41,200 | 104,926 | D |
| Bergstrom Donald A President, R&D | 2022-03-10 | Sale | −10,000 | $25.00 | $250,000 | 94,926 | D |
| Derivatives | |||||||
| Bergstrom Donald A President, R&D | 2022-03-10 | Option exercise · Stock Option (Right to Buy) | −10,000 | 227,456 | D | ||
| Open-market sales · 10,000 sh · avg $25.00 · $250,000 | |||||||
Loading xslF345X03/doc4.xml…